These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4333098)

  • 1. Activity of mouse interferon in human cells.
    Bodo G; Palese P; Lindner J
    Proc Soc Exp Biol Med; 1971 Sep; 137(4):1392-5. PubMed ID: 4333098
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular modification of interferon: attainment of human interferon in a conformation active on cat cells but inactive on human cells.
    Desmyter J; Stewart WE
    Virology; 1976 Apr; 70(2):451-8. PubMed ID: 178096
    [No Abstract]   [Full Text] [Related]  

  • 3. Investigations on a tissue antagonist of interferon (TAI).
    Fournier F; Rousset S; Chany C
    Proc Soc Exp Biol Med; 1969 Dec; 132(3):943-50. PubMed ID: 4311845
    [No Abstract]   [Full Text] [Related]  

  • 4. Interferon production by individual cells.
    Rodgers R; Merigan TC
    Virology; 1974 Feb; 57(2):467-74. PubMed ID: 4361456
    [No Abstract]   [Full Text] [Related]  

  • 5. Interference activity and sensitivity to interferon of original and "cold" strains of adenovirus types 1 and 2.
    Lysov VV; Aksenov OA; Rudenko VI; Moshkin SA; Yurlova TI; Smorodintsev AA; Selivanov AA
    Acta Virol; 1971 Sep; 15(5):387-92. PubMed ID: 4399137
    [No Abstract]   [Full Text] [Related]  

  • 6. PURIFIED INTERFERONS: PHYSICAL PROPERTIES AND SPECIES SPECIFICITY.
    MERIGAN TC
    Science; 1964 Aug; 145(3634):811-3. PubMed ID: 14163319
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferon and cell division. VII. Inhibitory effect of highly purified interferon preparations on the multiplication of leukemia L 1210 cells.
    Gresser I; Bandu MT; Tovey M; Bodo G; Paucker K; Stewart W
    Proc Soc Exp Biol Med; 1973 Jan; 142(1):7-10. PubMed ID: 4345725
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferon antagonists induced by Newcastle disease virus (NDV).
    Galliot B; Moreau MC; Renard N; Chany C
    Proc Soc Exp Biol Med; 1973 Jan; 142(1):266-70. PubMed ID: 4345719
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on virus-induced interferons produced by the human amniotic membrane and white blood cells.
    Duc-Goiran P; Galliot B; Chany C
    Arch Gesamte Virusforsch; 1971; 34(3):232-43. PubMed ID: 4330138
    [No Abstract]   [Full Text] [Related]  

  • 10. Purification of mouse and human interferons: detection of subunit structure.
    Carter WA
    Prep Biochem; 1971 Jan; 1(1):55-75. PubMed ID: 4110565
    [No Abstract]   [Full Text] [Related]  

  • 11. Kinetics of interferon production in human leukocyte suspensions.
    Tovell D; Cantell K
    J Gen Virol; 1971 Dec; 13(3):485-9. PubMed ID: 4334304
    [No Abstract]   [Full Text] [Related]  

  • 12. A micro assay for mouse and human interferon.
    Dahl H; Degré M
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1972; 80(6):863-70. PubMed ID: 4345661
    [No Abstract]   [Full Text] [Related]  

  • 13. Blocking of interferon production by chromatographically purified L cell interferon.
    Golgher RR; Paucker K
    Proc Soc Exp Biol Med; 1973 Jan; 142(1):167-74. PubMed ID: 4345714
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancing effect of interferon pretreatment on interferon production.
    Ito F; Kobayashi S
    Jpn J Microbiol; 1974 May; 18(3):223-8. PubMed ID: 4372434
    [No Abstract]   [Full Text] [Related]  

  • 15. Distinguishing characteristics of the interferon responses of primary and continuous mouse cell cultures.
    Stewart WE; Gosser LB; Lockart RZ
    J Gen Virol; 1971 Oct; 13(1):35-50. PubMed ID: 4331813
    [No Abstract]   [Full Text] [Related]  

  • 16. Preparative electrophoresis of isotopically labeled L-cell interferons.
    Stancek D; Paucker K
    Appl Microbiol; 1971 Jun; 21(6):1067-71. PubMed ID: 4327610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EVIDENCE FOR A PERSISTENT VIRAL INFECTION IN A CELL LINE DERIVED FROM BURKITT'S LYMPHOMA.
    HENLEGHENLE W
    J Bacteriol; 1965 Jan; 89(1):252-8. PubMed ID: 14255673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiviral and anticellular activity of human leukocytic and fibroblastic interferons in homo- and heterologous cells].
    Orlova TG; Zhdanov LV; Timofeev IV; Indikova IN; Mentkevich LM
    Vopr Virusol; 1981; (4):404-7. PubMed ID: 6171095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative aspects of interferon-induced plaque reduction: kinetics of interferon action.
    Jordan GW
    Virology; 1972 May; 48(2):425-32. PubMed ID: 4337029
    [No Abstract]   [Full Text] [Related]  

  • 20. Recovery of cell-bound interferon.
    Stewart WE; De Clercq E; De Somer P
    J Virol; 1972 Oct; 10(4):707-12. PubMed ID: 4343547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.